1. CPSA Standards of Practice - Prescribing Drugs with potential for misuse or diversion

2. Medscape: 11 Drugs You Should Seriously Consider Deprescribing

1. Topical Agents

   1. Clinical Journal of Pain, 2014. Topical Treatment of neuropathic pain using compounded medications.

   2. Diabetic Foot Canada Journal, 2016. The Use of Topical Analgesics in the Management of Painful Diabetic Neuropathy.

   3. Journal of Pain and Symptom Management, 2017. Topical Treatment of Peripheral Neuropathic Pain: Applying the Evidence.

2. acetaminophen

3. anesthetics

   1. Lidocaine

   2. Bupivacaine

4. Capsaicin

5. NSAID

   1. ibuprofen

   2. diclofenac

6. TCA

   1. amitriptyline

   2. nortriptyline

7. anticonvulsant

   1. gabapentin

   2. pregabalin

   3. oxcarbazepine

   4. Phenytoin

   5. Leviteracetam

   6. Lamotrigine (ref 1)

8. SSRI Recognition and Management of Antidepressant Discontinuation Syndrome (ADDS)

   1. citalopram

   2. fluoxetine

   3. sertraline

   4. paroxetine

9. SNRI

   1. duloxetine CMAJ 2017: harms/benefits

   2. venlafaxine

10. Opioids

    1. tramadol Tramacet

    2. codeine

    3. morphine

    4. hydromorphone

    5. oxycodone

    6. fentanyl

11. Cannabinoid

    1. nabilone

12. anti-spastic

    1. baclofen PO vs IV Side Effects

    2. tizanidine

    3. dantrolene

13. Cyclobenzaprine

14. Benzodiazepine

    1. Lorazepam

    2. Diazepam

    3. "Benzodiazepine & Z-Drug (BZRA) Deprescribing Algorithm"

    4. "Benzodiazepine Equivalency Table"

    5. "Is a Benzodiazepine or Z-drug still needed for Sleep?"

15. Botulinum toxin

    1. onabotulinum toxin A Migraine Headache Botox Monograph

    2. incobotulinum toxin A Cervical Dystonia

    3. abobotulinum toxin A

    4. 2002, Complications and adverse reactions with the use of botulinum toxin.

16. NMDA receptor antagonist

    1. dextromethorphan Article 1 Article 2 Article 3

17. Dopamine agonist

    1. Amantadine

    2. Ropinirole (Requip)

18. Stimulant

    1. Methylphenidate

    2. Modafinil

19. anti-platelet

    1. Aspirin

    2. Clopidogrel

20. Anti-coagulant

    1. Warfarin

    2. Dabigatran Praxbind (Idarucizumab)

    3. Apixaban

    4. Rivaroxaban

21. anti-fungal

    1. Clotrimazole (Canesten) Clotrimazole/Betamethasone (Lotrisone)

22. cholinergic

    1. Bethanechol

23. anti-cholinergic

    1. Oxybutynin

    2. Tolterodine (Detrol)

    3. Solifenacin (Vesicare)

24. beta-agonist

    1. Myrbetriq (Mirabegron)

25. steroids & derivatives

    1. Prednisone

    2. Methylprednisolone (depomedrol)

    3. Triamcinolone (Kenalog)

    4. Deflazacort FDA approval

26. Anti-psychotics

    1. "Is an Anti-Psychotic Still Needed?"

    2. "Anti-Psychotic Deprescribing Algorithm"

Journals

U of C Library Login Required

1. General Rehab Journals

2. Annals of Physical and Rehabilitation Medicine

3. Archives of Physical Medicine and Rehabilitation

4. Physical Medicine and Rehabilitation Clinics of North America

5. Stroke

6. Journal of Stroke and Cerebrovascular Diseases

1. 2017, JAMA. Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation.

2. 2017, CMAJ. Antidepressant Discontinuation Syndrome.

3. 2014. New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications.

4. 2014. Local Anesthetics - 10 Essentials.